Skip to content
Head to head

Inspire Medical Systems vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: INSP · ABT

Updated moments ago

1-year performance, rebased to 100

INSP -35.1%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories has done best over the past year (-15%); Abbott Laboratories pays the highest dividend yield.
INSPABT
Snapshot
SectorMedical DevicesMedical Devices
Last price55.10103.00
Change today-2.10%-0.84%
1-year return-33.8%-15.4%
Market cap$1.60B$178.39B
52-week range38.91 – 147.0380.89 – 126.70
Valuation
P/E (TTM)16.4538.29
P/E percentile, own 5-yr range69th99th
P/B1.933.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)4.893.72
Net profit (TTM)$141.64M$6.44B
Revenue (TTM)$880.94M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)-7.9%+14.5%
Gross margin86.2%56.9%
Operating margin1.8%13.8%
Net margin11.4%9.7%
Free cash flow (TTM)$97.89M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership128.9%81.2%
Insider activity (12mo)32 buy / 17 sell36 buy / 12 sell
Short interest (% of float)14.3%1.1%
Analyst consensus33% buy / 50% hold / 17% sell (12)93% buy / 7% hold (15)
Analyst price target$74 (+35%)$122 (+18%)
StockVane view
StockVane Quant RatingE (12)D (22)
Company
Employees1,333115,000
Founded20071900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.